Posts

I was very proud to introduce the Improving Access to Medicinal Cannabis Bill 2023. It has been too hard and too expensive for patients with severe conditions to access this drug.

One Nation’s will fix that for those in need of this amazing plant.

Transcript

Thank you, Madam Acting Deputy President. As a servant to the people of Queensland and Australia, I’m delighted to say that this bill holds enormous promise. For far too long, cannabis and hemp have been suppressed for reasons that have everything to do with established interests, and nothing to do with the merits of the plant.

That has hurt people for years and is hurting hundreds of thousands of people now. This bill addresses one area that has been holding back the Australian cannabis and hemp industry. Currently, there is no formal system for providing approvals for the export of medical cannabis and hemp.

The approval must apply, the producer, sorry, must apply to the minister for an ad-hoc approval. While approvals have been granted, the volumes are a fraction of the potential that this crop offers. The Export Control Act, 2020 came in this year and it allows the minister to make rules that govern the issue of exports certificates.

If a substance is on the list, rules are issued to regulate the export of that substance. Now cannabis and hemp were not originally included in that bill. This amendment corrects that. Cannabis and hemp growers and manufacturers can now have certainty about the rules for export.

Every grower is on the same footing. All who meet the rules can get an export licence and sell the product into the world market, and what a market that is? The cannabis and hemp market in Australia is expected to grow to a billion dollars in just four years and double that to $2 billion by 2028.

And at that time, our near neighbours in Asia, in the Asian market will exceed $10 billion. This is a wonderful opportunity, the start of a wonderful opportunity. Australia’s reputation as a high quality, safe supplier of food and medicine will help our producers take a significant share of that huge market.

And I must compliment the government’s decision to require all cannabis producers to follow the International Safety and Quality Standard known as the GMP, good manufacturing practise. Quality processing has been instrumental in growing our reputation for trusted product and that means a lot to people overseas and in Australia.

Internationally, the world market for cannabis and hemp is expected to reach $50 billion by 2030. Some of this growth is from the trend to legalise recreational cannabis, which I need to make clear, One Nation does not support.

We do support natural, Australian whole plant medical cannabis by way of doctor’s prescription to any person with a medical need, supplied by a pharmacist, subsidised on the PBS. I note that the government is also looking to reschedule low THC cannabis into schedule three as an over-the-counter, chemist-only medication.

One Nation supports that reschedule. We have long pushed for this. The Liberal government talks about market efficiency but in the cannabis market, we have nothing but over-regulation and disincentives to enter the market. This bill will help but there is much, much more to be done.

I draw the government’s attention to the review of the Narcotic Drugs act conducted by Professor McMillan, which reported almost 12 months ago, July 2019. Professor McMillan made 26 recommendations to improve the commercial efficiency of the cannabis market in Australia.

None, none of those recommendations have currently been implemented. Many of those recommendations dovetail nicely with the intent of the Export Control Legislation Amendment to develop an Australian export industry for cannabis and hemp.

The report calls for a reduction in the onerous conditions being applied to the industry and to people who work in it. These restrictions are an unnecessary and costly barrier to efficient quality production. They’re holding our farmers back, they’re holding everyone in the supply chain back and holding customers back.

Professor McMillan has recommended that a single licence be issued for all or some of cultivation, production, manufacture and research. This is instead of the individual licences currently being required at each step. The report also suggested licences be valid for five years rather than 12 months.

Now most exported cannabis and hemp is value added, allowing one producer to now grow, process, manufacturer and research new products and a five year licence guarantees the security of their investment, which improves the return of their investment.

By encouraging vertical integration, our producers can benefit from multiple profit centres and insulate against fluctuations in one area of this emerging market. Export opportunities will be enhanced by a wider range of products offered for sale. Volume and diversity resulting from export markets will benefit domestic patients as well.

So let me explain. Currently medical cannabis is prohibitively expensive. This is in part due to the high administrative, regulatory and security costs imposed on each stage of the process from cultivating or importing through to selling the product to a patient.

This high cost is spread across low volumes because of restricted access making each prescription too expensive for patients to afford. And that creates an ongoing cycle of high prices and low affordability leading to low volume which leads to high prices. It’s a vicious cycle.

This bill represents a way out of that self-defeating cycle by allowing for the current small domestic demand to be met from high volume, low cost export production. Medical cannabis is best used when the plant has been processed as little as possible. It is a wonderful natural product.

Conversion into vaping solutions, patches, topicals and capsules does not disturb the compound profile of the plant. It is a wonderful product. Since medical cannabis has been legal for many years in well, most nations on the planet, we are seeing an explosion in new hybridised varieties of medical strains of cannabis.

I’ve seen some of them myself. These have been developed to provide an optimum profile for a specific medical condition. This wonderful plant, and it has many varieties can be tailored to specific needs of patients. And there are many patients in desperate need of this.

Hundreds of different varieties are now available to the world market, hundreds. The more of these varieties that can be grown in Australia to support export demand, the greater the variety that will be available to supply domestic patients. People can have this marvelous natural plant tailored to suit their specific medical needs.

With a professional, efficient, and profitable export industry, Australian patients will be able to access the exact cannabis profile for their particular health condition at much reduced prices, much greater value. So as a senator from Queensland, I’m excited that we have a growing centre for cannabis excellence in Southport.

Our beautiful climate is perfectly suited to growing hemp for food, textiles, cosmetics, oil, building products, and so much more. Queensland will be on the forefront of this multi billion dollar export industry for both hemp and cannabis.

One Nation’s policy of restoring property rights for farmers and building more dams will deliver to our farmers the capacity to grow Australia’s agricultural capacity through hemp and cannabis. Before closing, I want to reiterate what our party leader, Senator Hanson said and express my thanks to Senator Coleman from the Liberal Party and Senator Kitching from the Labor Party.

It was them who made it possible because Senator Hansen and some of our staff have been pushing for this for years vigorously and it’s wonderful to see this step. Tiny though it is, it is a wonderful step. So thank you. In closing, may I suggest that the success of this bill will depend upon what the export rules for cannabis are.

To date, rules on medical cannabis and hemp have been so damn onerous. People were left wondering if the government was fair dinkum about a plant that has so many proven applications, and so many successful runs on the board overseas.

We look forward to the government proving through fair and effective regulation, that they are indeed genuine about implementing this bill’s attention, thank you.

One Nation has worked with the Government to pass legislation through the Senate to remove a major stumbling block that will expand the medical cannabis and hemp markets.

Senator Roberts said, “This is a game changer for the medical cannabis and hemp industries.”

The Certification of Narcotic Exports bill replaces the ad hoc approvals for exports with a streamlined process giving certainty to medical cannabis and hemp growers and manufacturers.

One Nation supports natural, whole plant medical cannabis via doctor’s prescription for a medical need, issued from a chemist and on the PBS, but does not support recreational use of cannabis.

“It is a lifeline for thousands of people currently forced to use illegal medical cannabis at high prices, as affordable legal cannabis is hard to obtain,” added Senator Roberts.

The bill will lead to a quick expansion of Australian production for export, which will bring about a greater range and lower prices for Australian patients.

Senator Roberts stated, “Export volumes assist local companies to grow plants with a wider range of profiles, allowing a patient to receive cannabis developed for their specific medical condition.”

“Australia has a unique competitive advantage with perfect climate, existing transport infrastructure and the international standard of Good Manufacturing Practice already in place.”

“Queensland is at the forefront of this multi-billion dollar export industry with a manufacturing facility at Southport, and expected growth to $1 billion over next four years.”

Hemp is known for its strength, durability and versatility, has wide application and its market growth looks promising. One Nation calls on the government to honour the intentions of this legislation and put in place export rules for cannabis that facilitate growers and manufacturers accessing export market.